We used targeted re-sequencing technology in a selected paediatric epilepsy cohort to investigate the role of early genetic testing to achieve a timely diagnosis of CLN2 and other genetic neurodevelopmental disorders featuring early epilepsy. Here, TPP1 is linked to epilepsy.